Cargando…
Novel therapies for graft versus host disease with a focus on cell therapies
Graft versus host disease (GVHD) can occur at any period post allogeneic hematopoietic stem cell transplantation as a common clinical complication contributing to significant morbidity and mortality. Acute GVHD develops in approximately 30-50% of patients receiving transplants from matched related d...
Autores principales: | Zeiser, Robert, Ringden, Olle, Sadeghi, Behnam, Gonen-Yaacovi, Gil, Segurado, Oscar G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585098/ https://www.ncbi.nlm.nih.gov/pubmed/37868964 http://dx.doi.org/10.3389/fimmu.2023.1241068 |
Ejemplares similares
-
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022) -
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020) -
Editorial: Non-coding RNAs and Graft versus Host Disease
por: Reddy, Pavan, et al.
Publicado: (2018) -
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017) -
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
por: Apostolova, Petya, et al.
Publicado: (2016)